Researcher
Shumei Chia is a Staff Scientist at the A*STAR Genome Institute of Singapore (A*STAR GIS). She obtained her PhD in Science (Molecular and Cell Biology) from the National University of Singapore in 2013, where she investigated molecular signalling pathways regulating actin-microtubule cytoskeletal crosstalk during cell migration.
She subsequently joined A*STAR GIS as a postdoctoral fellow, where she developed an innovative, AI/ML-driven Precision Oncology approach that utilises high throughput drug screens in patient-derived tumour models integrated with their molecular profiles to identify novel biomarkers of therapy response as well as alternative therapeutic vulnerabilities.
Currently, her research focuses on applying spatial profiling approaches to characterise alterations within the tumour microenvironment associated with response and resistance to immunotherapy.
Related Articles
Tailoring treatments to fit our genes
6 Jan 2026A new precision oncology platform taps into machine learning to guide colorectal cancer treatments based



